Prévisions du marché européen des réactifs et équipements de transfection jusqu’en 2030 – Analyse régionale – par produit (réactifs et instruments), méthode (méthodes virales, méthodes non virales et méthodes hybrides), application (recherche biomédicale, production de protéines et administration thérapeutique) et fin Utilisateur (universités et instituts de recherche et entreprises pharmaceutiques et biotechnologiques)

BMIRE00030436 | Pages: 112 | Medical Device | Jul 2024 | Type: Regional | Status: Published
Le marché européen des réactifs et équipements de transfection était évalué à 306,04 millions de dollars US en 2022 et devrait atteindre 555,46 millions de dollars US d’ici 2030 ; on estime qu\'il s\'enregistrera à un TCAC de 7,7 % de 2022 à 2030.

Les initiatives stratégiques des entreprises stimulent le marché européen des réactifs et des équipements de transfection

La transfection est l\'étape complexe du processus global de développement. un vecteur viral, qui comprend l\'adénovirus, le virus adéno-associé et le lentivirus. À mesure que les processus de fabrication augmentent, la transfection transitoire doit également être accélérée. Les fournisseurs d\'équipements de traitement, les développeurs de médicaments et les fournisseurs de matières premières se concentrent sur les collaborations pour développer des solutions rentables, pratiques et évolutives pour le développement et la mise à l\'échelle rapides des processus de fabrication de vecteurs viraux. À petite échelle, avec des volumes de matériel et des temps de transfert et de mélange planifiés, la transfection de cellules avec plusieurs plasmides devient réalisable. La mise à l\'échelle nécessite de l\'expérience dans l\'industrialisation de l\'étape de transfection, car la plupart des entreprises n\'ont qu\'une expérience de la transfection au niveau du laboratoire. Cependant, le volume de milieux de culture cellulaire et de réactifs de transfection requis pour étendre le processus à un niveau plus important peut s’avérer peu pratique, ce qui souligne la nécessité d’une optimisation. Néanmoins, l’élargissement de l’échelle de production est devenu courant ces dernières années avec la demande croissante de vecteurs viraux. Avec les nombreux défis associés aux processus de transfection à grande échelle, la meilleure approche pour augmenter la production consiste à réduire le processus plutôt qu’à l’intensifier. Cette approche descendante permet une identification claire des conditions qui auront un impact sur le procédé au niveau industriel, comme le volume de solution complexe de transfection. Cette approche facilite également l’optimisation des processus et la prise de décision. Le développement de telles approches pour accélérer les processus de transfection à petite échelle constitue une opportunité pour la croissance du marché européen des réactifs et des équipements de transfection.

Aperçu du marché européen des réactifs et équipements de transfection et région Europe segmentée en Royaume-Uni, Allemagne, France, Espagne, Italie et reste de l\'Europe. Le Royaume-Uni détient la plus grande part de marché en 2022. La croissance de l’industrie pharmaceutique est déterminée par la recherche et le développement de haute qualité en cours dans le pays et par une base de connaissances étendue et florissante en matière de soins de santé. Le Royaume-Uni est l\'un des meilleurs écosystèmes au monde en matière de recherche, de développement, de fabrication, d\'adoption clinique et de remboursement de produits thérapeutiques avancés. Actuellement, plus de 85 essais cliniques sont en cours au Royaume-Uni et 70 sociétés de la CGT s\'efforcent de développer des thérapies potentiellement curatives. Catapult est une entreprise de premier plan qui a contribué de manière significative à l\'écosystème CGT au Royaume-Uni ; elle figure parmi les cinq principales entreprises impliquées dans le développement de processus de fabrication de réactifs et de dispositifs dans le pays. L\'entreprise se concentre sur le développement de processus de fabrication CGT automatisés plus intelligents, capables de s\'adapter automatiquement aux environnements changeants et aux exigences des processus avec une intervention minimale. Par conséquent, les efforts déployés par les entreprises basées au Royaume-Uni pour améliorer la productivité et réduire les coûts du produit final sont les principaux facteurs qui stimulent la croissance du marché de la thérapie cellulaire et génique au Royaume-Uni. De plus, le Royaume-Uni occupe une position forte sur le marché européen de la thérapie cellulaire et génique grâce à des investissements soutenus et ciblés dans la recherche, qui profitent encore davantage au marché.

De plus, la France compte la présence de géants biopharmaceutiques et pharmaceutiques tels que Sanofi SA, Ipsen, Pierre Fabre, HRA Pharma et TxCell (Sangamo Therapeutics, Inc.). Ces entreprises sont impliquées dans le développement de vaccins et d’anticorps, entre autres, qui nécessitent une lyophilisation de leurs produits, ce qui contribue à la demande de réactifs et d’équipements de transfection.

Revenus et prévisions du marché européen des réactifs et équipements de transfection jusqu\'en 2030 (millions de dollars américains)

Segmentation du marché européen des réactifs et équipements de transfection

Le marché européen des réactifs et équipements de transfection est segmenté en fonction du produit, de la méthode, de l\'application, de l\'utilisateur final et du pays.

En fonction du produit, le marché européen des réactifs et des équipements de transfection est divisé en réactifs et instruments. Le segment des réactifs détenait une part plus importante en 2022.

En termes de méthode, le marché européen des réactifs et des équipements de transfection est segmenté en méthodes virales, méthodes non virales et méthodes hybrides. Le segment des méthodes non virales détenait la plus grande part en 2022. Le segment viral est sous-catégorisé en rétrovirus, adénovirus, virus adéno-associé et virus de l\'herpès. Le segment non viral est divisé en méthode physique/mécanique et méthode chimique. En outre, le segment des méthodes physiques/mécaniques est sous-catégorisé en électroporation, microinjection, méthode biolistique, méthode laser, magnétofection et sonoporation. En outre, le segment des méthodes chimiques est sous-catégorisé en liposomal/à haute teneur en lipides et non liposomal/à haute teneur en lipides.

Par application, le marché européen des réactifs et équipements de transfection est segmenté en recherche biomédicale, production de protéines et administration thérapeutique. Le segment de la recherche biomédicale détenait la plus grande part en 2022.

Sur la base de l\'utilisateur final, le marché européen des réactifs et des équipements de transfection est divisé en universités et instituts de recherche et entreprises pharmaceutiques et biotechnologiques. Le segment des universitaires et des instituts de recherche détenait une part plus importante en 2022.

En fonction des pays, le marché européen des réactifs et équipements de transfection est classé en Allemagne, France, Royaume-Uni, Italie, Espagne et reste de l\'Europe. Le Royaume-Uni a dominé le marché européen des réactifs et équipements de transfection en 2022.

Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, MaxCyte Inc et Polyplus-Transfection SA comptent parmi les principales sociétés opérant sur le marché européen des réactifs et des équipements de transfection.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Transfection Reagents and Equipment Market - Key Market Dynamics

4.1 Europe Transfection Reagents and Equipment Market - Key Market Dynamics

4.2 Market Drivers

4.2.1 Increasing Popularity of Cell and Gene Therapy

4.2.2 Growing Economic Burden of Cancer

4.3 Market Restraints

4.3.1 High Cost of Instruments and Consumables

4.4 Market Opportunities

4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes

4.5 Future Trends

4.5.1 Strategic Initiatives by Companies

4.6 Impact of Drivers and Restraints:

5. Transfection Reagents and Equipment Market - Europe Market Analysis

5.1 Europe Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030

5.2 Europe Transfection Reagents and Equipment Market Forecast Analysis

6. Europe Transfection Reagents and Equipment Market Analysis - by Product

6.1 Reagents

6.1.1 Overview

6.1.2 Reagents: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

6.2 Equipment

6.2.1 Overview

6.2.2 Equipment: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Transfection Reagents and Equipment Market Analysis - by Modality

7.1 Viral

7.1.1 Overview

7.1.2 Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.1.2.1 Retrovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.1.2.2 Adenovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.1.2.3 Adeno-Associated Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.1.2.4 Herpes Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2 Non-Viral

7.2.1 Overview

7.2.2 Non-Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1 Physical/Mechanical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1.1 Electroporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1.2 Microinjection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1.3 Biolistic Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1.4 Laser Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1.5 Magnetofection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.1.6 Sonoporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.2 Chemical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.2.1 Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.2.2.2.2 Non-Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Hybrid

7.3.1 Overview

7.3.2 Hybrid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Transfection Reagents and Equipment Market Analysis - by Application

8.1 Biomedical Research

8.1.1 Overview

8.1.2 Biomedical Research: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

8.2 Protein Production

8.2.1 Overview

8.2.2 Protein Production: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Therapeutic Delivery

8.3.1 Overview

8.3.2 Therapeutic Delivery: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Transfection Reagents and Equipment Market Analysis - by End Users

9.1 Academic and Research Institutes

9.1.1 Overview

9.1.2 Academic and Research Institutes: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

9.2 Pharmaceutical and Biotechnological Companies

9.2.1 Overview

9.2.2 Pharmaceutical and Biotechnological Companies: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Transfection Reagents and Equipment Market -Country Analysis

10.1 Europe: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country

10.1.1 Europe: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country

10.1.2 United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10.1.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Product

10.1.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Modality

10.1.2.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Viral

10.1.2.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Non-Viral

10.1.2.2.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method

10.1.2.2.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Chemical Method

10.1.2.3 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Application

10.1.2.4 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by End Users

10.1.3 Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10.1.3.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Product

10.1.3.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Modality

10.1.3.2.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Viral

10.1.3.2.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Non-Viral

10.1.3.2.2.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method

10.1.3.2.2.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Chemical Method

10.1.3.3 Germany: Transfection Reagents and Equipment Market Breakdown, by Application

10.1.3.4 Germany: Transfection Reagents and Equipment Market Breakdown, by End Users

10.1.4 France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10.1.4.1 France: Transfection Reagents and Equipment Market Breakdown, by Product

10.1.4.2 France: Transfection Reagents and Equipment Market Breakdown, by Modality

10.1.4.2.1 France: Transfection Reagents and Equipment Market Breakdown, by Viral

10.1.4.2.2 France: Transfection Reagents and Equipment Market Breakdown, by Non-Viral

10.1.4.2.2.1 France: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method

10.1.4.2.2.2 France: Transfection Reagents and Equipment Market Breakdown, by Chemical Method

10.1.4.3 France: Transfection Reagents and Equipment Market Breakdown, by Application

10.1.4.4 France: Transfection Reagents and Equipment Market Breakdown, by End Users

10.1.5 Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10.1.5.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Product

10.1.5.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Modality

10.1.5.2.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Viral

10.1.5.2.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Non-Viral

10.1.5.2.2.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method

10.1.5.2.2.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Chemical Method

10.1.5.3 Italy: Transfection Reagents and Equipment Market Breakdown, by Application

10.1.5.4 Italy: Transfection Reagents and Equipment Market Breakdown, by End Users

10.1.6 Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10.1.6.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Product

10.1.6.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Modality

10.1.6.2.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Viral

10.1.6.2.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Non-Viral

10.1.6.2.2.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method

10.1.6.2.2.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Chemical Method

10.1.6.3 Spain: Transfection Reagents and Equipment Market Breakdown, by Application

10.1.6.4 Spain: Transfection Reagents and Equipment Market Breakdown, by End Users

10.1.7 Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10.1.7.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Product

10.1.7.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Modality

10.1.7.2.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Viral

10.1.7.2.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Non-Viral

10.1.7.2.2.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method

10.1.7.2.2.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Chemical Method

10.1.7.3 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Application

10.1.7.4 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by End Users

11. Transfection Reagents and Equipment Market -Industry Landscape

11.1 Overview

11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023

11.3 Inorganic Growth Strategies

11.3.1 Overview

11.4 Organic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Thermo Fisher Scientific Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Promega Corp

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 F. Hoffmann-La Roche Ltd

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Bio-Rad Laboratories Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Mirus Bio LLC

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 QIAGEN NV

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Merck KGaA

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Lonza Group AG

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 MaxCyte Inc

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Polyplus-Transfection SA

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About Us

List of Tables

Table 1. Europe Transfection Reagents and Equipment Market Segmentation

Table 2. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Table 3. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product

Table 4. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality

Table 5. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral

Table 6. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral

Table 7. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method

Table 8. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method

Table 9. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application

Table 10. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users

Table 11. Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country

Table 12. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 13. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality

Table 14. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral

Table 15. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral

Table 16. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method

Table 17. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method

Table 18. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 19. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users

Table 20. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 21. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality

Table 22. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral

Table 23. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral

Table 24. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method

Table 25. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method

Table 26. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 27. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users

Table 28. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 29. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality

Table 30. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral

Table 31. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral

Table 32. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method

Table 33. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method

Table 34. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 35. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users

Table 36. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 37. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality

Table 38. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral

Table 39. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral

Table 40. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method

Table 41. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method

Table 42. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 43. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users

Table 44. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 45. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality

Table 46. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral

Table 47. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral

Table 48. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method

Table 49. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method

Table 50. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 51. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users

Table 52. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product

Table 53. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality

Table 54. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral

Table 55. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral

Table 56. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method

Table 57. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method

Table 58. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application

Table 59. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users

Table 60. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market

Table 61. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market

List of Figures

Figure 1. Europe Transfection Reagents and Equipment Market Segmentation, by Country

Figure 2. Impact Analysis of Drivers and Restraints

Figure 3. Europe Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030

Figure 4. Europe Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)

Figure 5. Reagents: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 6. Equipment: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Europe Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)

Figure 8. Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Retrovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Adenovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Adeno-Associated Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Herpes Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Non-Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Physical/Mechanical: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Electroporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Microinjection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Biolistic Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Laser Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Magnetofection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Sonoporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Chemical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Non-Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Hybrid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. Europe Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)

Figure 26. Biomedical Research: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. Protein Production: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 28. Therapeutic Delivery: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 29. Europe Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)

Figure 30. Academic and Research Institutes: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 31. Pharmaceutical and Biotechnological Companies: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

Figure 32. Europe: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)

Figure 33. Europe: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 34. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)

Figure 35. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)

Figure 36. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)

Figure 37. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)

Figure 38. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)

Figure 39. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)

Figure 40. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023

1. Thermo Fisher Scientific Inc
2. Promega Corp
3. F. Hoffmann-La Roche Ltd
4. Bio-Rad Laboratories Inc
5. Mirus Bio LLC
6. QIAGEN NV
7. Merck KGaA
8. Lonza Group AG
9. MaxCyte Inc
10. Polyplus-Transfection SA

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe transfection reagents and equipment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Europe transfection reagents and equipment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440